@article{0b8309738afa40439c7b6626208af85e,
title = "Strategies for assessing the impact of loss to follow-up on estimates of neurodevelopmental impairment in a very preterm cohort at 2 years of age",
abstract = "BACKGROUND: Loss to follow-up is a major challenge for very preterm (VPT) cohorts; attrition is associated with social disadvantage and parents with impaired children may participate less in research. We investigated the impact of loss to follow-up on the estimated prevalence of neurodevelopmental impairment in a VPT cohort using different methodological approaches.METHODS: This study includes births < 32 weeks of gestational age (GA) from 4 regions in the UK and Portugal participating in a European birth cohort (N = 1737 survivors). Data on maternal characteristics, pregnancy complications, neonatal outcomes and neighborhood deprivation were collected at baseline. Neurodevelopment was assessed at 2 years of corrected age (CA) using standardized parent-report measures. We applied (1) multiple imputation (MI) and (2) inverse probability weighting (IPW) to estimate the impact of non-response on the prevalence of moderate to severe neurodevelopmental impairment and assessed violations of the missing at random (MAR) assumption using the delta method.RESULTS: 54.2% of children were followed-up. Follow-up was less likely when mothers were younger, multiparous, foreign-born, did not breastfeed and came from deprived areas. The prevalence of neurodevelopmental impairment was 18.4% (95% confidence interval (CI):15.9-21.1) and increased to 20.4% (95%CI: 17.3-23.4) and 20.0% (95%CI:16.9-23.1) for MI and IPW models, respectively. Simulating strong violations of MAR (children with impairments being 50% less likely to be followed-up) raised estimates to 23.6 (95%CI:20.1-27.1) CONCLUSIONS: In a VPT cohort with high loss to follow-up, correcting for attrition yielded modest increased estimates of neurodevelopmental impairment at 2 years CA; estimates were relatively robust to violations of the MAR assumption.",
keywords = "Delta method, Inverse probability weighting, Loss to follow-up, Multiple imputation, Neurodevelopment, Preterm births",
author = "Aur{\'e}lie Piedvache and {van Buuren}, Stef and Henrique Barros and Ribeiro, {Ana Isabel} and Draper, {E. S.} and J. Zeitlin and {the EPICE Research group} and E. Martens and G. Martens and {Van Reempts}, P. and K. Boerch and A. Hasselager and Huusom, {L. D.} and O. Pryds and T. Weber and L. Toome and H. Varendi and France, {Ile de} and Ancel, {P. Y.} and B. Blondel and A. Burguet and Jarreau, {P. H.} and P. Truffert and Maier, {R. F.} and B. Misselwitz and S. Schmidt and L. Gortner and D. Baronciani and G. Gargano and R. Agostino and D. DiLallo and F. Franco and V. Carnielli and C. Koopman-Esseboom and {van Heijst}, A. and J. Nijman and J. Gadzinowski and J. Mazela and Gra{\c c}a, {L. M.} and Machado, {M. C.} and Carina Rodrigues and T. Rodrigues and Bonamy, {A. K.} and M. Norman and Boyle, {E. Wilson E.} and Draper, {E. S.} and Manktelow, {B. N.} and Fenton, {A. C.} and Milligan, {D. W.A.} and J. Zeitlin and M. Bonet",
note = "Funding Information: The research leading to these results received funding from the European Union{\textquoteright}s Seventh Framework Programme (FP7/2007–2013) under grant agreement No. 259882 and from the European Union{\textquoteright}s Horizon 2020 research and innovation programme under grant agreement No 733280. Funding Information: EPICE Research group: BELGIUM: Flanders (E Martens, G Martens, P Van Reempts); DENMARK: Eastern Region (K Boerch, A Hasselager, LD Huusom, O Pryds, T Weber); ESTONIA (L Toome, H Varendi); FRANCE: Burgundy, Ile-de France and Northern Region (PY Ancel, B Blondel, A Burguet, PH Jarreau, P Truffert); GERMANY: Hesse (RF Maier, B Misselwitz, S Schmidt), Saarland (L Gortner); ITALY: Emilia Romagna (D Baronciani, G Gargano), Lazio (R Agostino, D DiLallo, F Franco), Marche (V Carnielli), M Cuttini, I Croci; NETHERLANDS: Eastern & Central (C Koopman-Esseboom, A van Heijst, J Nijman); POLAND: Wielkopolska (J Gadzinowski, J Mazela); PORTUGAL: Lisbon and Tagus Valley (LM Gra?a, MC Machado), Northern region (Carina Rodrigues, T Rodrigues), H Barros; SWEDEN: Stockholm (AK Bonamy, M Norman, E Wilson); UK: East Midlands and Yorkshire and Humber (E Boyle, ES Draper, BN Manktelow), Northern Region (AC Fenton, DWA Milligan); INSERM, Paris (J Zeitlin, M Bonet, A Piedvache). STROBE guidelines were followed for reporting the background, methods and results of this observational cohort study. Publisher Copyright: {\textcopyright} 2021, The Author(s).",
year = "2021",
month = jun,
day = "6",
doi = "10.1186/s12874-021-01264-3",
language = "English",
volume = "21",
pages = "1--9",
journal = "BMC Medical Research Methodology",
issn = "1471-2288",
publisher = "BioMed Central",
number = "1",
}